CCR6 and metastatic malignant neoplasm: This hypothesis is not supported by our research results because we showed that the expression level of CCR6 mRNA was higher in NSCLC patients with diagnosed lymph nodes metastasis (N1 + N2) compared to non-metastatic cancer patients (N0).